Normally, C3G helps activate another protein called Rap1, but it keeps itself in check through a built-in “off switch.” However, a mutation found in some lymphoma patients disables this off switch, causing Rap1 to be constantly active. This evidence concerns the gene RAPGEF1 and lymphoma.